Ambit Biosciences Corp director was just granted 14,000 options


Mark G Foletta, a director of Ambit Biosciences Corp, just received 14,000 options from the company. The strike price of the options received was $11.09, and these expire on January 22, 2024. Foletta now owns at least 14,000 options on the company.

Some additional info was provided as follows:

One-third of the shares will vest on each of the first second and third year anniversaries of the date of grant.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever Ambit Biosciences Corp makes a similar move, sign up!

Other recent filings from the company include the following:

Prospectus [Rule 424(b)(3)] - Aug. 26, 2014
Ambit Biosciences Corp Just Received a Notice of Effectiveness - Aug. 26, 2014

   Auto Refresh

Feedback